Track the 药石科技 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 药石科技 has recorded 4 public disclosures. Market capitalisation: €8.9bn. The latest transaction was disclosed on 23 August 2024 (Purchase). Among the most active insiders: 刘郝敏. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
药石科技 es una empresa centrada en el sector de la salud y farmacéutico, que ofrece soluciones innovadoras para el tratamiento de enfermedades. Cotiza en el mercado XSHE.